Ad is loading...
EMGCX
Price
$20.95
Change
-$0.01 (-0.05%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

EMGCX vs RNWFX

Header iconEMGCX vs RNWFX Comparison
Open Charts EMGCX vs RNWFXBanner chart's image
Allspring Emerging Markets Equity C
Price$20.95
Change-$0.01 (-0.05%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
EMGCX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EMGCX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EMGCX is a Sell and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. EMGCX (3.73B). RNWFX pays higher dividends than EMGCX: RNWFX (1.51) vs EMGCX (0.00). EMGCX was incepted earlier than RNWFX: EMGCX (30 years) vs RNWFX (23 years). RNWFX is a more actively managed with annual turnover of: 32.00 vs. EMGCX (4.00). RNWFX has a lower initial minimum investment than EMGCX: RNWFX (250) vs EMGCX (1000). RNWFX annual gain was more profitable for investors over the last year : 11.54 vs. EMGCX (7.82). RNWFX return over 5 years is better than : 17.17 vs. EMGCX (-1.69).
EMGCXRNWFXEMGCX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence30 years23 years-
Gain YTD3.5597.09950%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRA250N/A-
Net Assets3.73B60.9B6%
Annual Yield % from dividends0.001.51-
Returns for 1 year7.8211.5468%
Returns for 3 years-18.80-14.55129%
Returns for 5 years-1.6917.17-10%
Returns for 10 years17.9641.0044%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics